H.R.1259 - Dextromethorphan Distribution Act of 2009 Sponsor: Frederick Upton / 111th Congress

Title
111th Congress - To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes. hidemore...
Summary
To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes. (by CRS)
Status
The bill was voted on in the House on March 31, 2009

Customize

Customize the interests supporting and opposing this bill

To remove an interest, click the Remove button next to its name below this box.

To add an interest, choose one from this list:

To add an interest, click Support or Oppose.

You can share your customized pages with other people by sending them the URL for pages about this bill. Other MAPLight.org users will not see your customizations unless they use the URL you send them. To save your customizations for your next visit, create a free New Account, then Sign In.

Done

Interests who did want this bill to become law included these interests and specific groups:

Interests who did not want this bill to become law included these interests and specific groups:

(None found)

Contribution data provided by the Center for Responsive Politics (OpenSecrets.org)

Comments RSS feed

H.R. 1259 Aims to Curb Recreational DXT Use by Lauren Christensen, Mar 19, 2009 (8:06pm)

The Dextromethorphan Distribution Act of 2009 is designed to stop the growing trend of its recreational use. Dextromethorphan[DXT] is an ingredient in most over-the-counter cough medicines that, according to the FDA, when used in appropriate doses, is not addictive and can help prevent many cold symptoms. However, when the drug is taken in excessive quantities, many of the side-effects are increased [dizziness, drowsiness, blurred vision, ect.] creating a “high”. Often mixed with alcohol, recreational DXT abuse is becoming common practice among teenagers. The bill plans to restrict access to the pure form of the drug to what it calls “legitimate entities” registered with the FDA. It is supported by pharmaceutical groups, anti-drug coalitions and drug stores. While I believe that it is a good idea to put regulations and restrictions on any drug that may be harmful, I’m not exactly sure how this legislation will address the problem of misuse of OTC cough medicine, which seems to be the central issue.

Reply to this comment
Reply to this comment close
[ Tags ]
[ Tags ] close
[ Spam ]
[ Spam ] close